Eight Steps to Streamlining – and Improving – Management of Your Diabetic Patients

Clinical Challenge

If you are like most primary care clinicians, you are drowning in the “tyranny of the urgent” and chaos of busy daily clinical practice. How can you find time to be more effective and efficient – to streamline your practice and engage your patients with type 2 diabetes more fully?

Learning Objectives: Upon completion of this educational activity, the participant should be able to:

• Identify systemic problems in their practices that may result in suboptimal care of patients with chronic illness such as type 2 diabetes. 

• Describe the characteristics of the Chronic Care Model and how they can implement it step-by-step in their practices to reduce systematic problems. 

• Save time and improve care by developing an ongoing communication plan at the practice level with their patients with diabetes.

• Identify actions that they can take in their practices to more fully engage patients as partners in their care.

Faculty: David McCulloch, MD
                Clinical Professor of Medicine/Endocrinology
                University of Washington, Seattle
                Medical Director, Clinical Improvement
                Group Health Cooperative
                Seattle, Washington

Estimated Time to Complete: 60-90 minutes

Amount of CME credit: Maximum of 1.5 AMA PRA Category 1 Credits^TM

Accreditation: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Pennsylvania School of Medicine and BestPractice CPD. The University of Pennsylvania School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Designation of Credit: The University of Pennsylvania School of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Supported, in part, by educational grants from Genentech, Inc., GlaxoSmithKline, Lilly USA LLC, and Takeda Pharmaceuticals North America, Inc.